Recruiting

Rapid Testing

Sponsor:

West Virginia University

Code:

NCT07317687

Conditions

HIV Testing

HEPATITIS C (HCV)

Syphilis

Hepatitis B Virus (HBV)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Rapid Fingerstick Test

Blood Draw for lab test

Study Details

Brief summary:

West Virginia faces rising rates of HIV, hepatitis, and syphilis, particularly among individuals experiencing homelessness, substance use, and mental health challenges. Traditional blood-draw testing for these infections is often hindered by mistrust, logistical barriers, and delays in results. This study, conducted by the West Virginia University (WVU) Street Medicine program, evaluates a rapid, point-of-care fingerstick test for HIV, Hepatitis C, and syphilis that provides results within 10-20 minutes during mobile clinic visits. Participants may choose rapid testing, traditional blood draw (which also includes Hepatitis B screening), or decline testing. All participants will be invited to complete a brief survey about the experiences with screening methods. The goal is to assess whether rapid testing improves screening uptake, linkage to care, and patient satisfaction, ultimately reducing barriers and disease burden in high-risk populations.

Conditions

HIV Testing

HEPATITIS C (HCV)

Syphilis

Hepatitis B Virus (HBV)

Study ID

NCT07317687

Start date

Jan 21, 2026

Status verified date

Jul, 2026

Completion date

Jan, 2028

Anticipated

Primary completion date

Jan, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Patients of the WVU Medicine Street Medicine team

Exclusion Criteria:

  • Patients under the age of 18

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Arms

Participants receiving fingerstick test

  • Will get a quick fingerstick test for HIV, Hepatitis C, and syphilis.
  • Will receive results in 10-20 minutes.
  • If positive, will be offered immediate care and/or a referral.
  • If positive, blood draw will be offered on site to confirm results or referred to a WVU Medicine clinic location for follow-up blood test.
  • Will be invited to answer survey questions about the feelings and experiences with screening (about 15-30 minutes).

Participants receiving blood-draw test

Participants receiving blood-draw test:

  • Will get a blood draw to test for HIV, Hepatitis B \& C, and syphilis
  • Will receive results in approximately 3 days (via MyChart message and phone call, or in person at site)
  • If positive, will be offered immediate care and/or a referral for follow-up care. • Will be invited to answer questions about the feelings and experiences with screening (about 15 minutes).

Participants who decline screening

Participants who decline screening:

• Will be invited to answer survey questions about the feelings and experiences with screening (about 15-30 minutes).

Interventions

Rapid Fingerstick Test

Fingerstick test for HIV, Hepatitis B and C, and Syphilis that gives results within 10-20 minutes

Blood Draw for lab test

Blood draw to test for HIV, Hepatitis B \& C, and syphilis which can take up to 3 days for results

Primary outcome measure

  • Percentage of Finger Stick [ Time Frame: Day 1 ]
  • Percentage of Blood Draw [ Time Frame: Day 1 ]
  • Percentage that decline screening [ Time Frame: Day 1 ]

Central Contacts and Locations

Central contacts

Dana Bechtold, DO

304-535-6343dana.bechtold@hsc.wvu.edu

Locations

WVU Department of Family Medicine - Eastern Division

Recruiting

Harpers Ferry, West Virginia, United States, 25425

Contacts

Dana Bechtold, DO

304-535-4108dana.bechtold@hsc.wvu.edu

Principal Investigator:

Dana Bechtold, DO

More Information

Sponsor

West Virginia University

Last update posted

Aug 13, 2026

Last verified

Jul, 2026

Keywords

  • Street Medicine
  • Rapid Fingerstick Testing

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-04. This information was provided to ClinicalTrials.gov by West Virginia University on 2026-08-13.